Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma

Jean-François Martini; Elizabeth R. Plimack; Toni K. Choueiri; David F. McDermott; Igor Puzanov; Mayer N. Fishman; Daniel C. Cho; Ulka Vaishampayan; Bradley Rosbrook; Kathrine C. Fernandez; Jamal C. Tarazi; Saby George; Michael B. Atkins

doi:10.1158/1078-0432.CCR-20-1408

Clinical Trials: Targeted Therapy

Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma

Jean-François Martini, Elizabeth R. Plimack, Toni K. Choueiri, David F. McDermott, Igor Puzanov, Mayer N. Fishman, Daniel C. Cho, Ulka Vaishampayan, Bradley Rosbrook, Kathrine C. Fernandez, Jamal C. Tarazi, Saby George and Michael B. Atkins

Jean-François Martini

1Pfizer Global Product Development–Oncology, San Diego, California.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jean-François Martini

Elizabeth R. Plimack

2Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: elizabeth.plimack@fccc.edu

Toni K. Choueiri

3Dana-Farber Cancer Institute, Boston, Massachusetts.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David F. McDermott

4Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Igor Puzanov

5Vanderbilt University Medical Center, Nashville, Tennessee.

6Roswell Park Comprehensive Cancer Center, Buffalo, New York.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mayer N. Fishman

7Moffitt Cancer Center, Tampa, Florida.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel C. Cho

8Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ulka Vaishampayan

9Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bradley Rosbrook

1Pfizer Global Product Development–Oncology, San Diego, California.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kathrine C. Fernandez

10Pfizer Global Product Development Oncology, Cambridge, Massachusetts.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jamal C. Tarazi

1Pfizer Global Product Development–Oncology, San Diego, California.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jamal C. Tarazi

Saby George

6Roswell Park Comprehensive Cancer Center, Buffalo, New York.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Saby George

Michael B. Atkins

11Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/1078-0432.CCR-20-1408 Published November 2020

Article
Figures & Data
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

PreviousNext

November 2020
Volume 26, Issue 21

Table of Contents
Table of Contents (PDF)
About the Cover
Editorial Board (PDF)

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma

Message Subject (Your Name) has forwarded a page to you from Clinical Cancer Research

Message Body (Your Name) thought you would be interested in this article in Clinical Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma

Clin Cancer Res November 1 2020 (26) (21) 5598-5608; DOI: 10.1158/1078-0432.CCR-20-1408

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma

Clin Cancer Res November 1 2020 (26) (21) 5598-5608; DOI: 10.1158/1078-0432.CCR-20-1408

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Main menu

User menu

Search

Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma

Purchase access

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Articles

Info for

About Clinical Cancer Research